During the past decade, Gunma University Hosptial conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Gunma University Hosptial" are "Psoriasis" (2 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Gunma University Hosptial" in a lesser frequency.

Most popular intervention types in "Gunma University Hosptial" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Mirikizumab" (3 trials), "Placebo" (2 trials) and "Secukinumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gunma University Hosptial" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Gunma University Hosptial". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Gunma University Hosptial, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Gunma University Hosptial, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".